Get Started

XGN

Exagen (XGN)

Exagen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XGN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
11/14/2022	4:14PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:XGN	Exagen Inc
11/14/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. Reports Third Quarter 2022 Results	NASDAQ:XGN	Exagen Inc
11/08/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. to Participate in Fourth Quarter Investor Conferences	NASDAQ:XGN	Exagen Inc
10/31/2022	4:05PM	GlobeNewswire Inc.	Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022	NASDAQ:XGN	Exagen Inc
10/17/2022	9:00AM	GlobeNewswire Inc.	Exagen Announces Appointment of John Aballi as CEO	NASDAQ:XGN	Exagen Inc
10/04/2022	8:25AM	GlobeNewswire Inc.	Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer	NASDAQ:XGN	Exagen Inc
09/20/2022	4:05PM	GlobeNewswire Inc.	Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting	NASDAQ:XGN	Exagen Inc
09/15/2022	4:05PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:XGN	Exagen Inc
09/01/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients	NASDAQ:XGN	Exagen Inc
08/04/2022	5:18PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:XGN	Exagen Inc
08/04/2022	4:08PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:XGN	Exagen Inc
08/04/2022	4:06PM	GlobeNewswire Inc.	Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA	NASDAQ:XGN	Exagen Inc
08/04/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. Reports Second Quarter 2022 Results	NASDAQ:XGN	Exagen Inc
07/25/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference	NASDAQ:XGN	Exagen Inc
07/21/2022	4:05PM	GlobeNewswire Inc.	Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022	NASDAQ:XGN	Exagen Inc
07/05/2022	8:25AM	GlobeNewswire Inc.	Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility	NASDAQ:XGN	Exagen Inc
06/21/2022	8:34AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
06/21/2022	8:34AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
06/21/2022	8:34AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
06/21/2022	8:30AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:XGN	Exagen Inc
06/09/2022	8:25AM	GlobeNewswire Inc.	Exagen Inc. Expands Coverage with MediNcrease	NASDAQ:XGN	Exagen Inc
05/26/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference	NASDAQ:XGN	Exagen Inc
05/16/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus	NASDAQ:XGN	Exagen Inc
05/14/2022	12:56AM	TipRanks	Exagen (XGN) Gets a Buy Rating from BTIG	NASDAQ:XGN	Exagen Inc
05/13/2022	8:39AM	TipRanks	Exagen (XGN) Gets a Buy Rating from KeyBanc	NASDAQ:XGN	Exagen Inc
05/11/2022	5:17PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:XGN	Exagen Inc
05/11/2022	4:06PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:XGN	Exagen Inc
05/11/2022	4:06PM	GlobeNewswire Inc.	Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test	NASDAQ:XGN	Exagen Inc
05/11/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. Reports First Quarter 2022 Results	NASDAQ:XGN	Exagen Inc
05/01/2022	12:00PM	GlobeNewswire Inc.	Exagen Announces Five-Week Campaign for Lupus Awareness Month	NASDAQ:XGN	Exagen Inc